Omada Health, Inc.: valuation
Price
$14.33
November 13, 2026Market cap $889M
What Ploutos Investor adds for Omada Health
Part of Ploutos Investor, €9.99 a month
- The full history: 3 fiscal years, from 2023
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- Profit over the last twelve months is well above what the business itself earned, because it includes large gains outside the business, such as on investments or from selling a business. The P/E is lower than the business alone would give.
- Earnings per share here are the last twelve months' earnings over today's shares, so they agree with the P/E. The number of shares changed a lot during the year, so they differ from the earnings per share the company filed, which use the year's average number of shares.
Valuation today
What the market pays for the company's earnings, cash flow, book value and revenue at $14.33 (November 13, 2026), beside the median of its past fiscal years.
- EV / EBIT
- 94.0
- EV / Revenue
- 1.9
- Earnings yield
- 1.6%
- FCF yield
- 3.2%
- Market cap
- $889M
- enterprise value $646M
What today's price assumes
The discounted cash flow model run backwards: not what the company is worth, but the growth the price takes for granted.
For a buyer at $14.33 who wants 9% a year, free cash flow would need to grow by about
+6.9%a year for ten years
- at 7% a year
- +2.2%
- at 9% a year
- +6.9%
- at 11% a year
- +10.8%
Arithmetic on the price, not a forecast. Starts from free cash flow of $28M over the last 12 months and net cash $243M, the same growth each year for ten years, then 2.5% a year forever. Try other numbers in the DCF calculator.
DCF calculator
What is Omada Health worth on your own assumptions?
The DCF calculator opens with the company's figures already filled in from its filings. You set how fast its cash flow grows and the return you ask for, and see the value those assumptions give.
- Free cash flow, 12 months
- $28M
- Net cash
- $243M
- Shares
- 62.04M
- FCF, 5-year average a year
- –
- Revenue, 5-year average a year
- +45.6%
- Price
- $14.33
The full analysis
What do Omada Health's filings show?
The multiples say what the market pays for Omada Health. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
What is OMDA's P/E?
OMDA's P/E is 63.4, on earnings per share of $0.23 over the last 12 months.
What is OMDA's P/FCF?
OMDA's P/FCF is 31.6: a market cap of $889M over $28M of free cash flow in the last 12 months. Put the other way, a free cash flow yield of 3.2%.
How do I work out what OMDA is worth?
With the DCF calculator: it opens with Omada Health's figures from its filings, you enter your assumptions for growth and the return you ask for, and see the value they give. The company pages give no price target of their own. A full analysis gives a fair-value range, which is an estimate, not a target.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. The estimated fair value, where shown, is our estimate, labelled as one: not a fact, not a score and not a recommendation to buy or sell.